Doxorubicin-GnRH Agonist Conjugate AEZS-108 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

NCT01240629 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

43

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer
Hormone-resistant Prostate Cancer
Recurrent Prostate Cancer
Stage IV Prostate Cancer

Interventions

OTHER: laboratory biomarker analysis
OTHER: questionnaire administration
DRUG: doxorubicin-GnRH agonist conjugate AEZS-108

Sponsor

University of Southern California

Collaborators

[object Object]
[object Object]